Miguel Seabra

Group Leader
miguel.seabra@research.fchampalimaud.org
Gr
ou
ps

Seabra

Publications

Antas P, Carvalho C, Cabral-Teixeira J, Lemos L, Seabra MC (2024)
Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases
Trends Mol Med 30 (2), 136-146 (doi:10.1016/j.molmed.2023.11.009)
Fonseca AF, Coelho R, Lopes-da-Silva M, Lemos L, Hall MJ, Oliveira D, Falcão AS, Tenreiro S, Seabra MC, Antas P (2024)
Modeling Choroideremia Disease with Isogenic Induced Pluripotent Stem Cells
Stem Cells Dev. 33 (19-20), 528-539 (doi:10.1089/scd.2024.0105)
Carvalho C, Lemos L, Antas P, Seabra MC (2023)
Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology
Front. Ophthalmol. (doi:10.3389/fopht.2023.1270561)
Xue K, Jolly JK, Barnard AR, Rudenko A, Salvetti AP, Patrício MI, Edwards TL, Groppe M, Orlans HO, Tolmachova T, Black GC, Webster AR, Lotery AJ, Holder GE, Downes SM, Seabra MC, MacLaren RE (2018)
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Nat Med 24 (10), 1507-1512 (doi:10.1038/s41591-018-0185-5)
Edwards TL, Jolly JK, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Black GC, Webster AR, Lotery AJ, Holder GE, Xue K, Downes SM, Simunovic MP, Seabra MC, MacLaren RE (2016)
Visual Acuity after Retinal Gene Therapy for Choroideremia
NEW ENGLAND JOURNAL OF MEDICINE 374 (20), 1996-8 (doi:10.1056/NEJMc1509501)
MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FP, Black GC, Lotery AJ, Downes SM, Webster AR, Seabra MC (2014)
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
LANCET 383 (9923), 1129-37 (doi:10.1016/S0140-6736(13)62117-0)
Loading
Please wait...